-
EHDN 2026 Part 2: What’s the latest news for Huntington’s disease clinical trials?
12 min read
Latest News
-
Largest creatine clinical trial for Huntington's disease halted after 'futility' analysis
4 min read
CREST-E, a trial of the supplement creatine, has been stopped after an early analysis found it couldn't show benefit
-
Should we worry about a huntingtin invasion?
5 min read
Cool lab experiments show the huntington's disease protein jumping between cells. Does this matter for HD patients?
-
EuroBuzz 2014 Video, day one
13 min read
Video of our first live session at the European Huntington's Disease Network Meeting.
-
EuroBuzz 2014 Video, day two
21 min read
Video of our second live session at the European Huntington's Disease Network Meeting.
-
Melatonin alterations in Huntington's disease help explain trouble with sleep
7 min read
Study shows HD patients have decreased levels of melatonin, which may explain why so many suffer from sleep problems
-
EuroBuzz 2014: day three
4 min read
Our third and final report on the 2014 European Huntington's Disease Network meeting in Barcelona
-
EuroBuzz 2014: day two
7 min read
HDBuzz reports on the second day of science at the European HD Network meeting in Barcelona
-
EuroBuzz 2014: day one
11 min read
Highlights from the opening day of the 2014 European Huntington's Disease network in Barcelona, Spain
-
Going toe-to-toe with tau: new insights into the chemical basis of Huntington’s disease
6 min read
Does tau protein – which causes problems in other neurodegenerative diseases – contribute to Huntington's disease?
-
New results bring BDNF therapies into focus
7 min read
Some unexpected findings suggest new ways to aim at an old target in HD
HDBuzz Trial Tracker
FDA accepts BLA for Priority Review, with a target decision date of 1 May 2027.
Show 8 more Show less
Updates from the ongoing Phase 3 INVEST-HD trial of votoplam
Updates from the Phase 1b/2a REGEN4HD trial of neural stem cell therapy hNSC-01
Updates from the ongoing Phase 2/3 FALCON-HD trial of SKY-0515
